Gray Market Drug Reform and Transparency Act of 2013

**see addendum pageImportation of prescription drugs (H.R. 3715, S. 2549) Drug Shortages and Gray Market (H.R. 1958) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862), Hydrocodone Rescheduling (H.R. 1285, S. 621), Dextromethorphan (S. 644)

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

**see addendum pageImportation of prescription drugs (H.R. 3715) Drug Shortages and Gray Market (H.R. 1958) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2437), Hydrocodone Rescheduling (H.R. 1285, S. 621), Dextromethorphan (S. 644)

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse, (S. 348, S. 1277, H.R. 4069, H.R. 4709), Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Drug shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs (H.R. 3715)

Client expense: $233,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

**see addendum pageImportation of prescription drugs (H.R. 3715) Drug Shortages (H.R. 1958) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069), Hydrocodone Rescheduling (H.R. 1285, S. 621, and NPRM Docket No. DEA-389), Dextromethorphan (S. 644)

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069); Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs (H.R. 3715)

Client expense: $267,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Implementation of Health Care Reform, Implementation of Generic Biologics, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar NamingH.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug. H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 H.R.1958 - Gray Market Drug Reform and Transparency Act of 2013 H.R.2186 - VALID Compounding Act of 2013 H.R. 2725 FDA Safety over Sequestration Act H.R. 3019 SAFE Compounded Drugs Act H.R. 3089 Compounding Clarity Act of 2013 H.R. 3204 Drug Quality and Security Act H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H Res - 161 Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs S.214 - Preserve Access to Affordable Generics Act S.504 - Fair and Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013 S 957 - Drug Supply Chain Security Act S 959 - Pharmaceutical Quality, Security, and Accountability Act

Client expense: $604,408 · Firm income: Not reported

**see addendum pageImportation of prescription drugs (H.R. 3715) Drug Abuse (S. 348, S. 1277) Hydrocodone Rescheduling (H.R. 1285, S. 621) Drug Shortages - Gray Market (H.R. 1958) Rx Pedigree (S. 959, S. 957, H.R.1919, H.R. 2186; H.R. 3204 - PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Dextromethorphan (S. 644)

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Rx Pedigree (S. 959, S. 957, H.R. 1919) (H.R. 2186) (H.R. 3204) (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277); Hydrocodone Rescheduling (H.R. 1285, S. 621) Dextromethorphan (S. 644); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs (H.R. 3715)

Client expense: $279,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

FY 2014 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug Importation/Re-Importation, Drug Shortages, Pharmaceutical Drug Compounding, Labeling of Generic DrugsH.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug. H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 H.R.1958 - Gray Market Drug Reform and Transparency Act of 2013 H.R.2186 - VALID Compounding Act of 2013 H.R. 3019 SAFE Compounded Drugs Act H.R. 3089 Compounding Clarity Act of 2013 H.R.3204 Drug Quality and Security Act H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H Res - 161 Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs S.214 - Preserve Access to Affordable Generics Act S.504 - Fair and Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013 S 957 - Drug Supply Chain Security Act S 959 - Pharmaceutical Quality, Security, and Accountability Act

Client expense: $579,690 · Firm income: Not reported

**see addendum pageImportation of prescription drugs Drug Abuse (S. 348, H.R. 1285, S. 621, S. 644, S. 1277) Drug Shortages - Gray Market (H.R. 1958) Rx Pedigree (S. 959, S. 957, H.R.1919, H.R. 2186) Prescription Drug Monitoring Program Counterfeit Drugs Drug Take Back (S. 1089)

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Rx Pedigree (S. 959, S. 957, H.R. 1919) (H.R. 2186) (H.R. 3204); Prescription Drug Monitoring Programs; Drug Abuse (S. 348), Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644), Prescription Drug Abuse (S. 1277); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs

Client expense: $285,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

FY 2014 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug Importation/Re-Importation, Drug Shortages, And Generic Drugs, Pharmaceutical Drug CompoundingH.R. 486 - Stop Tampering of Prescription Pills Act of 2013 H.R. 1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 H.R. 1958 - Gray Market Drug Reform and Transparency Act of 2013 H.R. 2186 - VALID Compounding Act of 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H. Res. - 161 Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs S.214 - Preserve Access to Affordable Generics Act S. 504 - Fair and Immediate Release of Generic Drugs Act S. 621 - Safe Prescribing Act of 2013 S. 957 - Drug Supply Chain Security Act S. 959 - Pharmaceutical Compounding S. Res. 97 - A resolution expressing the sense of the Senate that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs

Client expense: $524,888 · Firm income: Not reported

**see addendum pageImportation of prescription drugs Drug Abuse (S. 348), Hydrocodone Rescheduling (H.R. 1285, S. 621), Dextromethorphan (S. 644), Prescription Drug Abuse (S. 1277) Drug Shortages - Gray Market (H.R. 1958) Rx Pedigree (S. 959, S. 957, H.R. 1919) (H.R. 2186) Prescription Drug Monitoring Program Counterfeit Drugs

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Rx Pedigree (S. 959, S. 957, H.R. 1919, H.R. 2186); Prescription Drug Monitoring Programs; Drug Abuse (S. 348); Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Prescription Drug Abuse (S. 1277); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs

Client expense: $358,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE